BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) Operating Income

The latest operating income for BIOSU is $-2.2M as of June 2023. That compares with $-560K in the prior-year period — down 283.7% year over year. Investors often review this figure alongside BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, BIOSU's operating income moved from $-560K to $-2.2M — a 283.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s operating scale or balance-sheet position.

A operating income figure of $-2.2M for BIOSU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BIOSU's operating income ($-2.2M), review year-over-year change from $-560K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.